ArticleJournal of Cancer2024

Leveraging an immune cell signature to improve the survival and immunotherapy response of lung adenocarcinoma.

Jiacheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.